Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
J Frontier CoFRA:R0L +0.97%75 Debt-to-Equity is 3.28 as of Feb. 2026, which is 438% above its 10-year median of 0.61. GuruFocus rates FRA:R0L with a GF Score™ of 75/100 and a GF Value™ of €9.26. The stock has 11 warning signs investors should review. Among 560 Healthcare Providers & Services companies, J Frontier Co ranks worse than 95.71% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for J Frontier Co's Debt-to-Equity or its related term are showing as below:
FRA:R0L'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06 Med: 0.61 Max: 4.54
Current: 4.32
During the past 8 years, the highest Debt-to-Equity Ratio of J Frontier Co was 4.54. The lowest was 0.06. And the median was 0.61.
FRA:R0L's Debt-to-Equity is ranked worse than 95.71% of 560
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs FRA:R0L: 4.32
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
J Frontier Co Debt-to-Equity Related Terms
J Frontier Co Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for J Frontier Co's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
J Frontier Co Debt-to-Equity Competitor Comparison
For the Pharmaceutical Retailers subindustry, J Frontier Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
J Frontier Co Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, J Frontier Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where J Frontier Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
J Frontier Co (FRA:R0L) has a Debt-to-Equity of 3.28 as of Feb. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on J Frontier Co and its competitors. This is 438% above median its historical median of 0.61. Over the past decade, J Frontier Co's Debt-to-Equity has ranged from 0.06 to 4.54. According to the industry distribution chart, J Frontier Co ranks #536 out of 560 companies in the Healthcare Providers & Services industry, placing it in the top 95.7%.
Is J Frontier Co's Debt-to-Equity too high?
J Frontier Co's current Debt-to-Equity of 3.28 is 438% above median its 10-year median of 0.61. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 4.54. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. J Frontier Co's value of 3.28 is 681% above this industry median. Based on the distribution chart, J Frontier Co ranks #536 out of 560 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, J Frontier Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does J Frontier Co's Debt-to-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, J Frontier Co ranks #536 out of 560 companies for Debt-to-Equity. This places J Frontier Co in the lower half of its industry. The industry median Debt-to-Equity is 0.42. J Frontier Co's value of 3.28 is 681% above this benchmark. Historically, J Frontier Co's own Debt-to-Equity has ranged from 0.06 to 4.54 over the past decade. While the company's 10-year median is 0.61 vs. the industry median of 0.42, J Frontier Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 560 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. J Frontier Co's current Debt-to-Equity of 3.28 is 681% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on J Frontier Co and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. J Frontier Co's current Debt-to-Equity is 3.28, which is 438% above median its own 10-year median of 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J Frontier Co stock overvalued right now?
J Frontier Co (FRA:R0L) has a current Debt-to-Equity of 3.28. The stock's GF Value™ is €9.26, compared to a current price of €10.40 — trading 12.3% above its estimated fair value. The current Debt-to-Equity is 3.28, which is 438% above median its 10-year median of 0.61 and 681% above the Healthcare Providers & Services industry median of 0.42. J Frontier Co's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For J Frontier Co (FRA:R0L), the current Debt-to-Equity is 3.28 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is J Frontier Co (FRA:R0L) Overvalued in 2026?
Based on GuruFocus' analysis, J Frontier Co stock appears to be overvalued.
The current stock price of €10.40 is trading 12.3% above its estimated GF Value™ of €9.26.
Key valuation signals for FRA:R0L:
Debt-to-Equity: 3.28 (438% above median its 10-year median of 0.61)
GF Value™: €9.26 vs. price of €10.40 (12.3% above fair value)
Industry Position: 681% above the Healthcare Providers & Services median (#536 of 560)
No single metric tells the full story. See the FRA:R0L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:R0L has been successfully added to your 
